Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Vitrakvi (larotrectinib) Covered by Aetna (CVS Health) in Pennsylvania: Forms, Appeals, and Alternative Options

Quick Answer: Getting Vitrakvi (larotrectinib) Covered by Aetna (CVS Health) in Pennsylvania Vitrakvi requires prior authorization from Aetna (CVS Health) in Pennsylvania. To get approval: (1) Submit NTRK gene fusion test results confirming tumor positivity, (2) provide clinical documentation showing metastatic/unresectable disease, and (3) include records of prior therapies
5 min read

How to Get Opzelura (Ruxolitinib Cream) Covered by Aetna CVS Health in Florida: Prior Authorization, Appeals, and State Protections Guide

Answer Box: Getting Opzelura Covered by Aetna CVS Health in Florida Aetna CVS Health requires prior authorization for Opzelura (ruxolitinib cream) in Florida, with mandatory step therapy requiring documented failure of topical corticosteroids and calcineurin inhibitors first. Your fastest path to approval: (1) Have your dermatologist document prior failures of
5 min read

Myths vs. Facts: Getting Zolgensma (onasemnogene abeparvovec-xioi) Covered by Aetna (CVS Health) in Texas - Complete Appeals Guide

Answer Box: Getting Zolgensma Covered by Aetna in Texas Aetna (CVS Health) requires strict prior authorization for Zolgensma in Texas: patient under 24 months, confirmed bi-allelic SMN1 mutations, anti-AAV9 antibody titer ≤1:50, and certified gene therapy center administration. If denied, file internal appeal within 180 days, then request Independent
5 min read